Drugs seized from US manufacturer for cGMP violations
This article was originally published in SRA
Executive Summary
Federal law enforcement officers, at the request of the US Food and Drug Administration, have seized some 33 drug products in multiple strengths, as well as raw ingredients, from Caraco Pharmaceutical Laboratories’ plants in Detroit, Farmington Hills and Wixom, Michigan1. The FDA says the firm has not taken appropriate steps to correct violations of current good manufacturing practices at these locations.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.